RE-BVS – Piemonte Repository

Sfoglia per AUTORE
CERESOLI G
Collezione AOU Alessandria

Items : 17

Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund. in Tumori / Tumori. 2024 Jun;110(3):168-173. doi: 10.1177/03008916241229287. Epub 2024 Feb 19.

2024
ASL Cuneo 2
AOU Alessandria
ASL Città di Torino

Grosso F; Garassino MC; Ceresoli GL; Pasello G; Petraglia S; De Simone I; Cuppone F; Gauna R; Verderame F; Alabiso I; Dellepiane C; Biello F; Lo Russo G; Occhipinti M; Proto C; Mazzeo L; De Angelis AM; Torri V; Crivellari S; Delfanti S; Cerbone L;

BAP1 Loss, Nuclear Grading, and Nonepithelioid Features in the Diagnosis of Mesothelioma in Italy: Nevermore without the Pathology Report. in Journal of personalized medicine / J Pers Med. 2024 Apr 8;14(4):394. doi: 10.3390/jpm14040394.

2024
AOU Alessandria
AOU San Luigi di Orbassano

Galetta D; Ceresoli GL; Davolio MC; Dianzani I; Abate-Daga L; Sculco M; Malapelle U; Pisapia P; Grosso F; Spagnolo P; Tiseo M; Barbisan F; Righi L; Rossi G; Pasello G; Novello S; Bironzo P;

Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial. in JAMA oncology / JAMA Oncol. 2024 Apr 1;10(4):475-483. doi: 10.1001/jamaoncol.2023.6789.

2024
AOU Alessandria

Szlosarek PW; Creelan BC; Sarkodie T; Nolan L; Taylor P; Olevsky O; Grosso F; Cortinovis D; Chitnis M; Roy A; Gilligan D; Kindler H; Papadatos-Pastos D; Ceresoli GL; Mansfield AS; Tsao A; O'Byrne KJ; Nowak AK; Steele J; Sheaff M; Shiu CF; Kuo CL; Johnston A; Bomalaski J; Zauderer MG; Fennell DA;

Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial. in Lancet (London, England) / Lancet. 2023 Dec 16;402(10419):2295-2306. doi: 10.1016/S0140-6736(23)01613-6. Epub 2023 Nov 3.

2023
AOU Alessandria

Chu Q; Perrone F; Greillier L; Tu W; Piccirillo MC; Grosso F; Lo Russo G; Florescu M; Mencoboni M; Morabito A; Cecere FL; Ceresoli GL; Dawe DE; Zucali PA; Pagano M; Goffin JR; Sanchez ML; Gridelli C; Zalcman G; Quantin X; Westeel V; Gargiulo P; Delfanti S; Tu D; Lee CW; Leighl N; Sederias J; Brown-Walker P; Luo Y; et alii...

Epithelioid Pleural Mesothelioma Is Characterized by Tertiary Lymphoid Structures in Long Survivors: Results from the MATCH Study. in International journal of molecular sciences / Int J Mol Sci. 2022 May 21;23(10):5786. doi: 10.3390/ijms23105786.

2022
AOU Alessandria
ASL Alessandria

Ceresoli GL; Marchini S; Allavena P; Zucali PA; Muzio A; Delfanti S; De Angelis A; Libener R; Penpa S; Callari M; Inglesi A; Amodeo R; Lupi M; Bosetti C; Vedovelli L; De Simone I; Moracci L; Olteanu GE; Pezzuto F; Paracchini L; Mannarino L; Calabrese F; D'Incalci M; Grosso F;

A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2022 May;17(5):661-674. doi: 10.1016/j.jtho.2021.12.015. Epub 2022 Feb 1.

2022
AOU Alessandria

Whisenant JG; Baena J; Cortellini A; Huang LC; Lo Russo G; Porcu L; Wong SK; Bestvina CM; Hellmann MD; Roca E; Rizvi H; Monnet I; Boudjemaa A; Rogado J; Pasello G; Leighl NB; Arrieta O; Aujayeb A; Batra U; Azzam AY; Unk M; Azab MA; Zhumagaliyeva AN; Gomez-Martin C; Blaquier JB; Geraedts E; Mountzios G; Serrano-Montero G; Reinmuth N; et alii...

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study. in ESMO open / ESMO Open. 2022 Jun;7(3):100446. doi: 10.1016/j.esmoop.2022.100446. Epub 2022 Apr 12.

2022
AOU Alessandria

Mark M; Rusakiewicz S; Früh M; Hayoz S; Grosso F; Pless M; Zucali P; Ceresoli GL; Maconi A; Schneider M; Froesch P; Tarussio D; Benedetti F; Dagher J; Kandalaft L; von Moos R; Tissot-Renaud S; Schmid S; Metaxas Y;

Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations. in Cell death & disease / Cell Death Dis. 2022 Jul 15;13(7):612. doi: 10.1038/s41419-022-05073-4.

2022
AOU Alessandria

Mannarino L; Mirimao F; Panini N; Paracchini L; Marchini S; Beltrame L; Amodeo R; Grosso F; Libener R; De Simone I; Ceresoli GL; Zucali PA; Lupi M; D'Incalci M;

Final results of DIADEM, a phase II study to investigate the efficacy and safety of durvalumab in advanced pretreated malignant pleural mesothelioma. in ESMO open / ESMO Open. 2022 Dec;7(6):100644. doi: 10.1016/j.esmoop.2022.100644. Epub 2022 Dec 1.

2022
AOU Alessandria

Canova S; Ceresoli GL; Grosso F; Zucali PA; Gelsomino F; Pasello G; Mencoboni M; Rulli E; Galli F; De Simone I; Carlucci L; De Angelis A; Belletti M; Bonomi M; D'Aveni A; Perrino M; Bono F; Cortinovis DL;

Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Oct;22(10):1438-1447. doi: 10.1016/S1470-2045(21)00404-6. Epub 2021 Sep 6.

2021
AOU Alessandria

Pinto C; Zucali PA; Pagano M; Grosso F; Pasello G; Garassino MC; Tiseo M; Soto Parra H; Grossi F; Cappuzzo F; de Marinis F; Pedrazzoli P; Bonomi M; Gianoncelli L; Perrino M; Santoro A; Zanelli F; Bonelli C; Maconi A; Frega S; Gervasi E; Boni L; Ceresoli GL;

Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study. in Clinical lung cancer / Clin Lung Cancer. 2021 Jul;22(4):361-370.e3. doi: 10.1016/j.cllc.2020.06.028. Epub 2020 Jul 3.

2021
AOU Alessandria

Maconi A; Canova S; Rulli E; Torri V; Galli F; Hollander L; Sperandi F; Tiseo M; Pasello G; Zucali PA; Carlucci L; Grosso F; Cortinovis D; Bidoli P; Ceresoli GL; D'Incalci M;

Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDE. in Journal of bone oncology / J Bone Oncol. 2020 Dec 2;26:100341. doi: 10.1016/j.jbo.2020.100341. eCollection 2021 Feb.

2021
AOU Alessandria

Panebianco F; Carlini P; Sartori D; Lanzetta G; Mencoboni M; Acquati M; Fagnani D; Ceresoli GL; D'Angelillo RM; Chiuri VE; Guglielmini PF; Bordonaro R; Gasparro D; Cinieri S; Santini D; Beccaglia P; Procopio G;

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment. in Frontiers in oncology / Front Oncol. 2021 Mar 22;11:653497. doi: 10.3389/fonc.2021.653497. eCollection 2021.

2021
AOU Alessandria

Pezzuto F; Lunardi F; Vedovelli L; Fortarezza F; Urso L; Grosso F; Ceresoli GL; Kern I; Vlacic G; Faccioli E; Schiavon M; Gregori D; Rea F; Pasello G; Calabrese F;

Incidence and outcomes of severe acute respiratory syndrome coronavirus 2 infection in patients with metastatic castration-resistant prostate cancer. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Nov;140:140-146. doi: 10.1016/j.ejca.2020.09.018. Epub 2020 Oct 20.

2020
AOU Alessandria

Caffo O; Gasparro D; Di Lorenzo G; Volta AD; Guglielmini P; Zucali P; Bortolus R; Cavo A; Ceresoli G; Chiari R; Fornarini G; Fratino L; Iaculli A; Maruzzo M; Masini C; Morelli F; Mucciarini C; Procopio G; Sabbatini R; Verri E; Kinspergher S; Maines F; Messina C; Veccia A; Donini M;

Tumour Treating Fields for mesothelioma - Authors' reply. in The Lancet. Oncology / Lancet Oncol. 2020 Jan;21(1):e10. doi: 10.1016/S1470-2045(19)30831-9.

2020
AOU Alessandria

Ceresoli GL; Gianoncelli L; Grosso F;

Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16). in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Apr;31(4):495-500. doi: 10.1016/j.annonc.2019.12.009. Epub 2020 Jan 16.

2020
AOU Alessandria

Metaxas Y; Früh M; Eboulet EI; Grosso F; Pless M; Zucali PA; Ceresoli GL; Mark M; Schneider M; Maconi A; Perrino M; Biaggi-Rudolf C; Froesch P; Schmid S; Waibel C; Appenzeller C; Rauch D; von Moos R;

Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2019 Dec;20(12):1702-1709. doi: 10.1016/S1470-2045(19)30532-7. Epub 2019 Oct 15.

2019
AOU Alessandria

Ceresoli GL; Aerts JG; Dziadziuszko R; Ramlau R; Cedres S; van Meerbeeck JP; Mencoboni M; Planchard D; Chella A; Crinò L; Krzakowski M; Rüssel J; Maconi A; Gianoncelli L; Grosso F;